ABB

Texas Governor Claims State’s Economy Could Surpass France’s, Thanks to Trump Policies

7 days ago

In a bold statement during a recent press conference, Texas Governor Greg Abbott proclaimed that the Lone Star State's economy is on track to surpass that of France, attributing this ambitious projection to the economic policies previously implemented by former President Donald Trump. Abbott's comments come amidst a backdrop of economic growth in Texas, which he argues has outpaced many other states and countries, showcasing the success of lower taxes and deregulation.

ABB CEO Warns of Looming Job Losses in Europe Due to Energy Costs

27 days ago

In a stark warning to European leaders, the CEO of ABB, a global technology giant, has raised concerns about the potentially devastating impact of soaring energy prices on the job market across the continent. According to CEO Björn Rosengren, the combination of high energy costs and increasing competition from nations with lower operational expenses could result in significant job losses in the region.

Republican Senators Call for FBI Background Checks on Notable Figures Amid Controversy

1 month ago

In a significant political maneuver reflecting rising tensions within the Republican Party, several GOP senators are advocating for FBI background checks on three prominent figures: Congressman Matt Gaetz, Fox News contributor Pete Hegseth, and former Democratic congresswoman Tulsi Gabbard. This development comes in the wake of increasing scrutiny over the backgrounds and associations of influential party members as the 2024 elections approach.

AbbVie’s New Schizophrenia Drug Suffers Major Setback in Clinical Trials

1 month ago

AbbVie, the biopharmaceutical giant known for its innovative drug portfolio, has experienced a significant downturn following disappointing results from two large-scale clinical trials of its investigational drug for schizophrenia. This development has sent ripples through the pharmaceutical sector, resulting in a substantial drop in the company’s stock price.

Abbott and Reckitt Unit Exonerated in Baby Formula Trial: A Landmark Decision

2 months ago

In a significant legal outcome, a federal jury has acquitted both Abbott Laboratories and a unit of Reckitt Benckiser of any liability linked to the controversial baby formula linked to a tragic case involving the death of an infant due to bacterial infections. The jury deliberated for over four hours before reaching a unanimous verdict, clearing the companies of negligence claims in a trial that underscored the intense scrutiny surrounding infant nutrition products.

AbbVie Raises Profit Outlook as Rinvoq and Skyrizi Outperform Expectations

2 months ago

In a significant update from the biopharmaceutical giant AbbVie, the company has revised its profit expectations upward following strong performance from its inflammatory drugs, Rinvoq and Skyrizi. This development, reported on October 30, 2024, signals a promising trend in AbbVie's growth strategy and showcases the resilience of its product pipeline amidst a competitive market landscape.

Abbott Adjusts 2024 Projections, Fuelled by Medical Device Innovation

2 months ago

Abbott Laboratories recently updated its financial forecasts for the year 2024, indicating a narrowed range that reflects its ongoing commitment to expanding its medical devices segment. The company's revised outlook suggests robust growth driven by an increased demand for its innovative healthcare solutions, particularly in the diagnostic and therapeutic sectors.